Physician profile
Bashar Omarbasha
NPI 1992766992
$14,604.14
in general payments reported to CMS, 2019-2025
51 companies · $1,501 in 2025
The $1,501 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,713 · 2020: $817 · 2021: $1,434 · 2022: $2,080 · 2023: $3,295 · 2024: $1,764 · 2025: $1,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,222 · Travel and Lodging: $308 · Gift: $16.65 · Education: $13.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,222.36 |
| Travel and Lodging | $308.40 |
| Gift | $16.65 |
| Education | $13.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,259.35 | 2019-2020 | |
| Coloplast Corp | $1,916.20 | 2019-2025 | Altis, Titan, Coloplast Tfl Drive |
| Boston Scientific Corporation | $1,088.18 | 2019-2025 | Axonics, Lithovue, General - Erectile Dysfunction |
| Axonics, INC. | $910.21 | 2020-2024 | Bulkamid, Axonics |
| Teleflex LLC | $890.05 | 2021-2023 | Urolift |
| Medtronic, INC. | $731.90 | 2021-2025 | Interstim, Altaviva |
| Abbvie INC. | $631.09 | 2019-2025 | |
| Astellas Pharma US INC | $517.16 | 2019-2024 | Myrbetriq, Xtandi |
| Antares Pharma, INC. | $501.11 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $494.88 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $286.09 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $283.24 | 2021-2024 | Jelmyto |
| Merck Sharp & Dohme LLC | $282.95 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Myriad Genetic Laboratories, INC. | $272.54 | 2020-2024 | Prolaris |
| Janssen Biotech, INC. | $227.54 | 2019-2025 | Erleada |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $222.19 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $220.46 | 2019-2024 | Xiaflex |
| Telix Pharmaceuticals | $209.68 | 2022-2025 | Illuccix |
| Ferring Pharmaceuticals INC. | $199.37 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $189.81 | 2019-2024 | |
| Urovant Sciences INC | $185.11 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $157.40 | 2019-2021 | |
| Histosonics, INC. | $142.42 | 2025 | |
| Procept Biorobotics Corporation | $135.75 | 2025 | |
| Palette Life Sciences, INC. | $129.58 | 2022 | |
| Genzyme Corporation | $124.99 | 2021 | |
| Caldera Medical, INC | $121.22 | 2021-2022 | |
| Endo USA, INC. | $118.14 | 2024-2025 | Xiaflex |
| Myovant Sciences INC. | $98.22 | 2021-2022 | |
| Dentsply Ih INC. | $96.47 | 2022 | |
| Tolmar, INC. | $96.26 | 2023-2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $92.32 | 2023-2024 | Gemtesa, Orgovyx |
| Olympus America INC. | $79.38 | 2023-2025 | Itind System |
| 180 Medical, INC. | $73.40 | 2019-2024 | Gentlecath, Gentlecath Glide |
| Clarus Therapeutics INC. | $68.18 | 2021 | |
| Allergan, INC. | $60.36 | 2020-2021 | |
| Rigicon,INC. | $58.67 | 2023 | Rigi10 Malleable Penile Prosthesis |
| Halozyme INC | $52.12 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $51.76 | 2024 | |
| Novo Nordisk INC | $48.18 | 2022-2025 | Rivfloza |
| Medtronic USA, INC. | $42.03 | 2019-2020 | |
| Bard Access Systems, INC. | $39.81 | 2019 | |
| Smith+Nephew, INC. | $33.04 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $31.99 | 2022-2023 | Seglentis |
| Blue Earth Diagnostics | $30.65 | 2020 | |
| Kerecis Limited | $19.42 | 2022 | |
| Convatec INC. | $18.31 | 2022 | |
| Dentsply Ih Ab | $17.87 | 2025 | Lofric |
| Alnylam Pharmaceuticals INC. | $17.82 | 2025 | Givlaari |
| Astrazeneca Pharmaceuticals Lp | $14.85 | 2024 | Lynparza |
| Avadel Specialty Pharmaceuticals, LLC | $14.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Omarbasha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.